MedTrace Logo

Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease

NCT00013923 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2009-12-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.

Conditions

  • Alzheimer Disease

Interventions

DRUG

Nutritional Supplement

Sponsors & Collaborators

  • Burke Medical Research Institute

    collaborator OTHER

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • John P Blass, MD, PhD · Burke Medical Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2005-06-30
Completion
2005-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00013923 on ClinicalTrials.gov